Dr. Chadwick Troy Flowers, MD

Dr. Flowers practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Flowers' NPI, 1952729832, was assigned on March 28, 2014. Dr. Flowers graduated from Indiana University School Of Medicine in 2014. Dr. Flowers holds Florida license ME135734.

Dr. Flowers' primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Flowers' primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Flowers is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Flowers to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Flowers practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Flowers' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Flowers is board certified in internal medicine by the American Board of Internal Medicine. Dr. Flowers is licensed in Florida.

Dmand AI lists acute respiratory failure, cardiac arrhythmia, circulation problems, congestive heart failure, heart attack, inflammatory bowel disease (IBD), liver disease and pneumonia and respiratory infection among the conditions Dr. Flowers treats.

CMS data shows 268 Medicare services from Dr. Flowers across 5 procedure codes in 2024, for 94 Medicare patients. Medicare paid $22,203 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 94 Medicare patients who saw Dr. Flowers in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 63% are also on Medicaid. Their average risk score is 3.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Flowers' median patient age at 68, with 53% women.

In 2024, Dr. Flowers wrote 554 Medicare Part D claims for 136 patients. 83% of them were for generic drugs. CMS names the drug for 250 of them, across 13 drugs with 11 or more claims each, at $31,823 in total drug cost. In 2023, CMS named 182 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Flowers for performance year 2024, reported as part of a group. Dr. Flowers accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Flowers from 2 drug and device companies in 2016. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $122.

Dr. Flowers graduated from Indiana University School Of Medicine in 2014.

Dr. Flowers is in network with 11 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.